News

U.S. Cymbalta cost highest in international comparison


 

The cost of duloxetine is considerably higher in the United States than in other industrialized countries, according to a report from the International Federation of Health Plans.

The average price for a 1-month supply of duloxetine (Cymbalta) was $176 in the United States, which is 56% higher than in Canada ($113) and 274% higher than in France, where the cost was lowest at $47, the IFHP said. Duloxetine is used to treat depression, anxiety, and pain.

The IFHP consists of more than 80 companies in 25 countries. For the survey, the price of duloxetine for each country was submitted by participating member plans. Some prices are drawn from the public sector, some from the private, and some from both. Estimates for the United States are aggregates based on over 100 million claims paid by multiple health plans.

rfranki@frontlinemedcom.com

Recommended Reading

Obama's budget proposal gives more power to IPAB
MDedge Rheumatology
ACP and FSMB offer social media guidelines
MDedge Rheumatology
Health exchanges could bring unpleasant surprises
MDedge Rheumatology
Battling over the budget: The Policy & Practice Podcast
MDedge Rheumatology
More than 23% of uninsured didn't take medications as prescribed
MDedge Rheumatology
Storify: After Boston Marathon blasts, doctors rush to help
MDedge Rheumatology
Emergency physicians share lessons from Boston Marathon bombings response
MDedge Rheumatology
Lawmakers take aim at ACA implementation: The Policy & Practice podcast
MDedge Rheumatology
Supreme Court ponders patenting of human genes
MDedge Rheumatology
Navigating the new insurance exchanges
MDedge Rheumatology